• Cefiderocol Activity Against Resistant P. aeruginosa and Aci

  2026-05-05

  This study systematically compares the in vitro efficacy of cefiderocol to β-lactam/β-lactamase inhibitor combinations against European clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp., including those resistant to meropenem and other last-line agents. The findings inform antibiotic selection strategies and resistance mechanism analysis in multidrug-resistant Gram-negative pathogens.

• (S)-(+)-Dimethindene maleate: Use in M2 Muscarinic Antagonis

  2026-05-04

  (S)-(+)-Dimethindene maleate provides a selective, high-purity M2 muscarinic receptor antagonist for research into autonomic regulation, cardiovascular, and respiratory system signaling. It is not suitable for diagnostic or therapeutic use, and its storage and experimental preparation require strict adherence to product specifications to ensure reliability.

• A-769662: AMPK Activator Workflows for Energy Metabolism Res

  2026-05-04

  A-769662 empowers metabolic researchers with precise, reversible AMPK activation, enabling robust dissection of energy metabolism and fatty acid synthesis inhibition. Leverage this tool for advanced autophagy and proteasome studies, with actionable troubleshooting and protocol insights.

• TPPU and the sEH–Nrf2 Pathway: Bridging Redox and Bone Healt

  2026-05-03

  This thought-leadership article unpacks the emerging role of TPPU, a potent soluble epoxide hydrolase inhibitor, in translational research targeting the liver-bone axis, redox imbalance, and inflammatory pain. Grounded in fresh mechanistic findings, it provides actionable guidance for experimental design, discusses the competitive landscape, and outlines future opportunities in chronic inflammation and osteoporosis research.

• Sodium Phosphate Dibasic: Optimizing Biological Assay Buffer

  2026-05-02

  Sodium phosphate dibasic (Na2HPO4) is indispensable as a high-purity pH stabilizer and buffer in aquatic toxicology and molecular biology, enabling reliable, reproducible results even in demanding assays. Leveraging APExBIO’s Na2HPO4 (SKU B7293) transforms complex environmental and protein assay workflows, with practical troubleshooting strategies guided by the latest peer-reviewed evidence.

• Q-VD(OMe)-OPh (SKU A8165): Reliable Caspase Inhibition for A

  2026-05-01

  This article offers scenario-driven, evidence-based guidance for biomedical researchers seeking reproducible caspase inhibition in apoptosis assays. Highlighting SKU A8165 (Q-VD(OMe)-OPh) from APExBIO, it addresses experimental design, assay optimization, and data interpretation challenges, referencing peer-reviewed studies and quantitative performance data.

• PP2A-Regulated Autophagy Drives Candida albicans Biofilm Dru

  2026-05-01

  This study elucidates how protein phosphatase 2A (PP2A) enhances drug resistance in Candida albicans biofilms via autophagy induction through ATG protein phosphorylation. The findings highlight PP2A-autophagy as a regulatory axis in antifungal resistance, offering new targets for therapeutic intervention and experimental modeling.

• Zolmitriptan as a 5-HT1B Receptor Agonist for Migraine Resea

  2026-04-30

  Zolmitriptan is a selective 5-HT1B/1D/1F serotonin receptor agonist widely utilized in migraine research. Its mechanism involves cranial vasoconstriction and inhibition of neuropeptide release, supporting its use as a robust research compound for studying migraine and cluster headaches. APExBIO provides high-purity Zolmitriptan (B2261) with validated solubility and handling parameters.

• Proximity Labeling Reveals Dynamic Synaptic Protein Traffick

  2026-04-30

  Pascual-Caro and de Juan-Sanz (2024) introduce a rapid, synaptic cleft-targeted proximity labeling technique that enables the quantification of activity-driven trafficking of endogenous synaptic proteins. This approach overcomes previous limitations in resolving the transient surface exposure of vesicular proteins during neuronal activity and provides new insights into synaptic molecular dynamics.

• Berberine Hydrochloride: Mechanistic Insights & Protocols

  2026-04-29

  Berberine hydrochloride is a potent AMPK activator with antibacterial and metabolic regulatory properties. It modulates lipid metabolism, upregulates LDL receptors, and suppresses anti-apoptotic proteins in cancer research. This article delivers evidence-based benchmarks and actionable protocols for metabolic and cardiovascular disease models.

• SR-202 (PPAR Antagonist): Mechanistic and Benchmark Dossier

  2026-04-29

  SR-202, a selective PPARγ antagonist, inhibits PPAR-dependent adipogenesis and improves insulin sensitivity in preclinical models. This article details its specificity, utility in metabolic research, and mechanistic benchmarks, with verifiable citations. Applications in obesity and type 2 diabetes research are critically examined.

• Miltefosine: Optimizing Neutrophil Differentiation via PI3K/

  2026-04-28

  Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) uniquely modulates both PI3K/Akt and Ras/MEK/ERK pathways to drive neutrophil differentiation and cell survival, offering translational leverage for hematology and oncology research. This guide distills workflow optimizations, troubleshooting, and protocol decisions to maximize the molecule’s impact in bench-to-bedside applications.

• Optimizing Forensic Detection with DFO (9H-1,8-Diazafluoren-

  2026-04-28

  This article provides a scenario-driven, evidence-based guide to leveraging DFO (9H-1,8-Diazafluoren-9-one) (SKU C6997) for sensitive, reproducible latent fingerprint detection on porous substrates. Researchers and lab technicians will find practical workflow insights and protocol parameters that enhance reliability and interpretability, especially when working with amino acid-reactive fluorescent dyes in forensic applications.

• Primidone and Aromatase: Evidence for Selective Enzyme Inter

  2026-04-27

  Jacobsen et al. (2008) systematically evaluated the inhibitory effects of twelve antiepileptic drugs on human aromatase (CYP19), clarifying their potential impact on steroidogenesis and associated endocrine outcomes. Notably, Primidone (Mysoline) exhibited no inhibition of aromatase activity, distinguishing it from several commonly used AEDs and supporting its use where hormonal side effects are a concern.

• GDC-0941: Protocols and Advances in PI3K Inhibitor Research

  2026-04-27

  GDC-0941 sets the benchmark for selective PI3K/Akt pathway inhibition, empowering researchers to dissect oncogenic signaling and overcome resistance in cancer models. This guide provides step-by-step workflows, data-driven troubleshooting, and actionable insights for maximizing GDC-0941’s translational impact.

14946 records 1/997 page Next 12345 下5页 Last page